Latest filing published 03 Sept 2026 for VIMAB Group AB (publ), €9,414. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Lars Peter Fredell, listed as chief executive, appears in our data through filings on VIMAB Group AB (publ) shares, published by Finansinspektionen. The record holds 8 filings, for trades running from 13 March 2025 to 31 August 2026.
Every open-market trade on record is a purchase: 8 purchases worth €86k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €7,387. Scaled by market value, the purchases weigh a median 0.037% of market cap (sample: 8 purchases). Clusters matter here: 3 out of 8 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 3 September 2026 came the latest disclosure, an open-market purchase for €9,414 in VIMAB Group AB (publ). The median gap between a trade and its publication by Finansinspektionen is 4 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations